A Prospective Cohort Study of the Effect of Depot Medroxyprogesterone Acetate on Detection of Plasma and Cervical HIV-1 in Women Initiating and Continuing Antiretroviral Therapy

被引：14
|
作者：
Day, Summer [1 ]
Graham, Susan M. [1 ,2 ]
Masese, Linnet N. [3 ]
Richardson, Barbra A. [4 ,5 ,6 ]
Kiarie, James N. [7 ]
Jaoko, Walter [2 ]
Mandaliya, Kishorchandra [8 ]
Chohan, Vrasha [1 ,6 ]
Overbaugh, Julie [6 ]
McClelland, R. Scott [1 ,2 ,3 ,5 ]
机构：
[1] Univ Washington, Dept Med, Seattle, WA 98104 USA
[2] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[3] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA
[4] Univ Washington, Dept Biostat, Seattle, WA 98104 USA
[5] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[7] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya
[8] Pathcare Labs, Mombasa, Kenya
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2014年 / 66卷 / 04期
基金：
美国国家卫生研究院;
关键词：
hormonal contraception; HIV-1; antiretroviral therapy; DMPA; HORMONAL CONTRACEPTION; COMPETING RISKS; TRANSMISSION; ACQUISITION; ADHERENCE; RNA;
D O I：
10.1097/QAI.0000000000000187
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Depot medroxyprogesterone acetate (DMPA) use among HIV-1-infected women may increase transmission by increasing plasma and genital HIV-1 RNA shedding. We investigated associations between DMPA use and HIV-1 RNA in plasma and cervical secretions. One hundred two women initiated antiretroviral therapy, contributing 925 follow-up visits over a median of 34 months. Compared with visits with no hormonal contraception exposure, DMPA exposure did not increase detection of plasma (adjusted odds ratio: 0.81, 95% confidence interval: 0.47 to 1.39) or cervical HIV-1 RNA (adjusted odds ratio: 1.41, 95% confidence interval: 0.54 to 3.67). Our results suggest that DMPA is unlikely to increase infectivity in HIV-positive women who are adherent to effective antiretroviral therapy.
引用
收藏
页码：452 / 456
页数：5
相关论文
共 50 条
  • [21] Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study
    Del Romero, Jorge
    Castilla, Jesus
    Hernando, Victoria
    Rodriguez, Carmen
    Garcia, Soledad
    BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 : 1179
  • [22] Risk of tuberculosis disease in people living with HIV after initiating antiretroviral therapy: A Danish nationwide prospective cohort study
    Virdee, A. K.
    Knudtzen, F. C.
    Llibre, J. M.
    Omland, L.
    Obel, N.
    Staerke, N. B.
    Ahsberg, J.
    Orsted, I.
    Kronborg, G.
    Mohey, R.
    Montejo, M. D. P. Fernandez
    Johansen, I. S.
    Martin-Iguacel, R.
    HIV MEDICINE, 2023, 24 : 608 - 611
  • [23] Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA
    Gianella, Sara
    von Wyl, Viktor
    Fischer, Marek
    Niederoest, Barbara
    Battegay, Manuel
    Bernasconi, Enos
    Cavassini, Matthias
    Rauch, Andri
    Hirschel, Bernard
    Vernazza, Pietro
    Weber, Rainer
    Joos, Beda
    Guenthard, Huldrych F.
    ANTIVIRAL THERAPY, 2011, 16 (04) : 535 - 545
  • [24] Genital HIV-1 viral load is correlated with blood plasma HIV-1 viral load in Brazilian women and is reduced by antiretroviral therapy
    Vettore, MV
    Schechter, M
    Melo, MF
    Boechat, LJ
    Barroso, PF
    JOURNAL OF INFECTION, 2006, 52 (04) : 290 - 293
  • [25] Effect of initiating antiretroviral therapy on markers of monocyte activation, endothelial dysfunction and platelet activation in HIV-1 infection
    O'Halloran, J. A.
    Dunne, E.
    Gurwith, M. M. P.
    Lambert, J. S.
    Sheehan, G. J.
    Feeney, E. R.
    Pozniak, A.
    Reiss, P.
    Kenny, D.
    Mallon, P. W. G.
    ANTIVIRAL THERAPY, 2014, 19 : A9 - A10
  • [26] Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care
    Kalayjian, Robert C.
    Lau, Bryan
    Mechekano, Rhoderick N.
    Crane, Heidi M.
    Rodriguez, Benigno
    Salata, Robert A.
    Krishnasami, Zipporah
    Willig, James H.
    Martin, Jeffrey N.
    Moore, Richard D.
    Eron, Joseph J.
    Kitahata, Mari M.
    AIDS, 2012, 26 (15) : 1907 - 1915
  • [27] Effect of antiretroviral therapy on the mortality of HIV-1 infection long-term non-progressors: a cohort study
    Su, Jinming
    Liu, Jie
    Qin, Fengxiang
    Chen, Rongfeng
    Qin, Tongxue
    Tao, Xing
    Chen, Xiu
    Hong, Wen
    Liang, Bingyu
    Cui, Ping
    Ye, Li
    Jiang, Junjun
    Liang, Hao
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [28] Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients
    Ahuja, TS
    Niaz, N
    Velasco, A
    Watts, B
    Paar, D
    CLINICAL NEPHROLOGY, 1999, 51 (01) : 40 - 44
  • [29] Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy
    Graham, Susan M.
    Masese, Linnet
    Gitau, Ruth
    Richardson, Barbra A.
    Mandaliya, Kishor
    Peshu, Norbert
    Jaoko, Walter
    Ndinya-Achola, Jeckoniah
    Overbaugh, Julie
    McClelland, R. Scott
    SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 (02) : 114 - 117
  • [30] A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy
    Graham, Susan M.
    Rajwans, Nimerta
    Tapia, Kenneth A.
    Jaoko, Walter
    Estambale, Benson B. A.
    McClelland, R. Scott
    Overbaugh, Julie
    Liles, W. Conrad
    BMC INFECTIOUS DISEASES, 2013, 13
12345